The ability of the Geneva homologous recombination deficiency (HRD) test to predict progression-free survival (PFS) in patients with high-grade ovarian cancer treated with poly (ADP-ribose) polymerase ...

Mindera Health, a leader in precision medicine for dermatological conditions, today announced it has received approval from the New York State Department of Health for its Mind.Px test. Mind.Px is a ...

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates. In clinical practice, indirect ...

Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...

Progress in cutting the global toll of cancer remains painfully slow, but a new blood test has sparked unusual levels of hope. Researchers say it could one day make routine screening far more ...

Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast ...